Janus Henderson Group
CGEM icon

Janus Henderson Group’s Cullinan Oncology CGEM Stock Holding History

Janus Henderson Group’s Portfolio CGEM Stock Details CGEM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$263K Hold
18,528
– – ﹤0.01% 2265
2025
Q4 		$191K Hold
18,528
– – ﹤0.01% 2354
2025
Q3 		$110K Hold
18,528
– – ﹤0.01% 2385
2025
Q2 		$139K Hold
18,528
– – ﹤0.01% 2376
2025
Q1 		$149K Hold
18,528
– – ﹤0.01% 2420
2024
Q4 		$226K Hold
18,528
– – ﹤0.01% 2382
2024
Q3 		$310K Hold
18,528
– – ﹤0.01% 2249
2024
Q2 		$323K Buy
+18,528
New +$395K ﹤0.01% 2173
2021
Q2 		– Sell
-173,471
Closed -$7.23M – 1618
2021
Q1 		$7.23M Buy
+173,471
New +$7.04M ﹤0.01% 950

Other funds holding CGEM

LCM
Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.64B AUM 245.64% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
BOCH
Blue Owl Capital Holdings New York $665M AUM 95.48% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return

Janus Henderson Group's CGEM Position: Q1 2026 in Review

Janus Henderson Group held its Cullinan Oncology (CGEM) position steady in Q1 2026 at 18,528 shares worth $263K. The position accounts for ﹤0.01% of the portfolio, ranked #2265.

Janus Henderson Group first reported a position in CGEM in Q1 2021 and has held it in 9 quarters since. The position peaked at $7.23M in Q1 2021. 174 funds tracked by Wall St. Rank hold CGEM as of Q1 2026.

  • Janus Henderson Group held 18,528 shares of Cullinan Oncology worth $263K as of Q1 2026.
  • Janus Henderson Group left its Cullinan Oncology share count unchanged in Q1 2026.
  • Cullinan Oncology made up ﹤0.01% of Janus Henderson Group's portfolio in Q1 2026, its #2265 holding.
  • Janus Henderson Group first reported a position in Cullinan Oncology in Q1 2021 and has held it in 9 quarters since.
  • Janus Henderson Group's Cullinan Oncology position peaked at $7.23M in Q1 2021.
  • 174 funds tracked by Wall St. Rank held Cullinan Oncology as of Q1 2026.

Based on Janus Henderson Group's 13F filing for Q1 2026, filed 15 May 2026.